Literature DB >> 15572382

Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.

Juhani Myllymäki1, Teemu Honkanen, Jaana Syrjänen, Heikki Helin, Immo Rantala, Amos Pasternack, Jukka Mustonen.   

Abstract

BACKGROUND: Immunoglobulin-A nephropathy (IgAN) is the most common chronic glomerulonephritis worldwide. Many clinical and histopathological risk factors for progression have been found previously. Recently, metabolic risk factors, such as hyperuricaemia and hypertriglyceridaemia, also have been associated with the progression of IgAN.
METHODS: In the present study we correlated clinical and metabolic risk factors with histopathological parameters in 202 patients with IgAN. Morphological changes in glomerular, tubulointerstitial and vascular tissue were semiquantitatively graded into three classes. Mesangial proliferation activity and the amount of inflammatory cells were also evaluated by immunohistochemical staining of Ki-67 (MIB-1), CD45 (LCA) and CD68 stainings. Serum uric acid, triglycerides and cholesterol, urine protein excretion (UPE), blood pressure and body mass index (BMI) were measured. Smoking habits and occurrence of diabetes mellitus also were evaluated. The independent role of serum uric acid in the development of renal morphological changes was evaluated in multivariate analysis.
RESULTS: Serum uric acid and UPE level correlated with several histological parameters. Uric acid level showed the strongest correlation with tubulointerstitial changes and UPE with glomerulosclerosis. The level of serum triglycerides correlated with interstitial fibrosis and hyaline arteriolosclerosis. Blood pressure correlated with hyaline arteriolosclerosis, glomerulosclerosis and tubulointerstitial changes. BMI and diabetes mellitus correlated with both tubulointerstitial and vascular changes. We found no significant correlations between histopathological parameters and smoking habits or serum cholesterol level. Serum uric acid had independent associations with the presence of tubular atrophy and interstitial fibrosis and inflammation.
CONCLUSIONS: We conclude that many metabolic factors are univariately associated with renal morphological findings in IgAN. These same factors are central in the metabolic or insulin resistance syndrome and may have a pathogenetic role in the progression of IgAN. Serum uric acid may have an independent role in development of tubulointerstitial lesions as well as being associated with inflammation in renal tissue of patients with IgAN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572382     DOI: 10.1093/ndt/gfh584

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  32 in total

1.  Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature.

Authors:  A C Kalil; J Mattei; D F Florescu; J Sun; R S Kalil
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 2.  Urate reduction and renal preservation: what is the evidence?

Authors:  Nicolas Macías; Marian Goicoechea; M S García de Vinuesa; Ursula Verdalles; Jose Luño
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

Review 3.  The role of necrotic cell death in the pathogenesis of immune mediated nephropathies.

Authors:  Neelakshi R Jog; Roberto Caricchio
Journal:  Clin Immunol       Date:  2014-05-17       Impact factor: 3.969

4.  Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study.

Authors:  Petter Bjornstad; David M Maahs; Christopher J Rivard; Laura Pyle; Marian Rewers; Richard J Johnson; Janet K Snell-Bergeon
Journal:  Acta Diabetol       Date:  2014-06-15       Impact factor: 4.280

5.  Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study.

Authors:  Jaana Ronkainen; Marja Ala-Houhala; Helena Autio-Harmainen; Timo Jahnukainen; Olli Koskimies; Jussi Merenmies; Jukka Mustonen; Timo Ormälä; Juha Turtinen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2006-07-13       Impact factor: 3.714

6.  Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial.

Authors:  Yongjun Shi; Wei Chen; Diana Jalal; Zhibin Li; Wenfang Chen; Haiping Mao; Qiongqiong Yang; Richard J Johnson; Xueqing Yu
Journal:  Kidney Blood Press Res       Date:  2011-11-23       Impact factor: 2.687

Review 7.  Hyperuricemia and renal risk.

Authors:  Francesca Viazzi; Giovanna Leoncini; Elena Ratto; Roberto Pontremoli
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-31

8.  Expression of prorenin receptor in renal biopsies from patients with IgA nephropathy.

Authors:  Nagisa Miyazaki; Ichijiro Murata; Genzou Takemura; Hideshi Okada; Hiromitsu Kanamori; Jun Matsumoto-Miyazaki; Gakuro Yoshida; Kumiko Izumi; Hitomi Kashi; Kaori Niimi; Ayuko Nishiwaki; Tatsuhiko Miyazaki; Michiya Ohno; Hiroshige Ohashi; Fumiaki Suzuki; Shinya Minatoguchi
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

9.  Uric acid level and erectile dysfunction in patients with coronary artery disease.

Authors:  Yalcin Solak; Hakan Akilli; Mehmet Kayrak; Alpay Aribas; Abduzhappar Gaipov; Suleyman Turk; Santos E Perez-Pozo; Adrian Covic; Kim McFann; Richard J Johnson; Mehmet Kanbay
Journal:  J Sex Med       Date:  2013-09-25       Impact factor: 3.802

10.  Hyperuricemia is associated with progression of IgA nephropathy.

Authors:  Ali Bakan; Alihan Oral; Omer Celal Elcioglu; Mumtaz Takir; Osman Kostek; Abdullah Ozkok; Semih Basci; Abdullah Sumnu; Savas Ozturk; Murat Sipahioglu; Aydın Turkmen; Luminita Voroneanu; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2015-03-12       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.